• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Translation initiation factor eIF-2B subunit epsilon (EIF2B5)

ACP17778

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP17778 Target NameEIF2B5
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range2-721Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ13144
Background Information
  • Uniprot Id

    Q13144

  • Target Species

    Human

  • Target Name

    EIF2B5

  • Target Full Name

    Translation initiation factor eIF2B subunit epsilon

  • Target Function

    Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP.

  • Target Involvement

    Leukodystrophy with vanishing white matter (VWM)

  • Target Protein Families

    EIF-2B gamma/epsilon subunits family

  • Target Synonyms

    CACH; CLE; EI2BE_HUMAN; EIF 2B; eIF 2B GDP GTP exchange factor; eIF 2B GDP GTP exchange factor subunit epsilon; eIF-2B GDP-GTP exchange factor subunit epsilon; EIF2B; EIF2B5; EIF2BE; EIF2Bepsilon; Eukaryotic Translation Initiation Factor 2 Beta Epsilon; Eukaryotic translation initiation factor 2B subunit 5 epsilon 82kDa; Eukaryotic translation initiation factor 2B subunit 5 epsilon; LVWM; Translation initiation factor eIF 2B subunit epsilon; Translation initiation factor eIF-2B subunit epsilon

Inquire Recombinant Human Translation initiation factor eIF-2B subunit epsilon (EIF2B5) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification